In addition to the anti-inflammatory effect of Hsp90 inhibitors, the induction of other Hsp chaperones has been recognized as a beneficial effect in experimental disease models of neuronal aggregation diseases, such as Alzheimer’s, Parkinson’s, or Huntington’s diseases [52]. The gene discussed is HSP90AA1; the disease is Huntington disease.